Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
27,163,993
-
Number of holders
-
143
-
Total 13F shares, excl. options
-
23,633,969
-
Shares change
-
+324,376
-
Total reported value, excl. options
-
$677,565,419
-
Value change
-
+$11,461,734
-
Put/Call ratio
-
172%
-
Number of buys
-
72
-
Number of sells
-
62
-
Price
-
$28.68
Institutional Holders of Arcturus Therapeutics Holdings Inc. - Common Stock, par value $0.001 per share (ARCT) as of Q2 2023
As of 30 Jun 2023 Arcturus Therapeutics Holdings Inc. - Common Stock, par value $0.001 per share (ARCT) had 143 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 23,633,969 shares of stock of the company.
Largest 10 holders included FEDERATED HERMES, INC., BlackRock Inc., STATE STREET CORP, ARK Investment Management LLC, VANGUARD GROUP INC, Nikko Asset Management Americas, Inc., Sumitomo Mitsui Trust Holdings, Inc., Woodline Partners LP, FMR LLC, and DIMENSIONAL FUND ADVISORS LP.
This table shows 143 institutional shareholders of the security as of 30 Jun 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.